H3 Biomedicine - An Oncology Discovery Company home  |  sitemap  |  contact us  
 search

 
  ABOUT USH3 Scientific ApproachNews & PublicationsCAREERS AT H3  
   
 
1
2
3
 
   
         
   

H3 Biomedicine Inc. is a unique oncology discovery enterprise guided by the vision of scientific founders and partnered with Eisai, Inc. Headquartered in Cambridge, MA, H3 Biomedicine is integrating human cancer genomics with next-generation synthetic organic chemistry and tumor biology capabilities to generate a large library of novel small-molecule drugs to treat cancer.
 

Careers at H3   Scientific Approach   H3 News
 

H3 Biomedicine offers a dynamic, entrepreneurial environment where team members can focus exclusively on scientific excellence. If you welcome a challenge and would like a career in a unique, highly autonomous and intensely collaborative work place, we invite you to explore opportunities at H3 today!

     

H3 Biomedicine’s disciplined approach to drug discovery, which effectively closes the gaps between genomic insight and small-molecule drug development, is highly prolific, supports rapid clinical development of drug candidates and is designed to produce patient-targeted medicines with excellent efficacy.

     

APRIL 30, 2012
Horizon Discovery and H3 Biomedicine Collaborate to Identify and Validate Novel, Patient-Relevant Cancer Targets


FEBRUARY 14, 2012
Compendia Bioscience and H3 Biomedicine announce strategic collaboration to apply cancer genomics to discover and develop next generation cancer therapeutics